By DengYueMed International Business DivisionToday, DengYueMed shares key commercial insights into China’s EGFR small-molecule targeted therapy market with international buyers and distribution partners. Drawing on the latest publicly available data, we analyzed the sales trends ...Learn More

Market Overview and ProjectionsThe Insight Partners announces the release of a new report, "An In-depth Analysis of the Event Industry Market," providing a holistic view of the market's current trajectory and future growth estimates. The market is undergoing significant ...Learn More

United States of America– 11 Nov 2025- The Insight Partners has released its newest report, "An In-depth Analysis of the India Staffing and Recruitment Market," offering a holistic view of the market, its current scenario, and growth projections during the forecast period.Market ...Learn More

United States of America– 11 Nov 2025- The Insight Partners is proud to announce its newest market report, "An In-depth Analysis of the Patient-Derived Xenograft Model Market". The report provides a holistic view of the markets and describes the current scenario as well as ...Learn More

As November 2025 arrives, the global pharmaceutical industry stands at a pivotal moment.In October alone, China saw six innovative drugs approved for market launch, including the world’s first EGFR-targeting Antibody–Drug Conjugate (ADC), Becotatugvedotin for Injection.This ...Learn More